Back to search results

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Abroad (travel likely)RecruitingPHASE4

Conditions

Primary Immune Thrombocytopenia (ITP)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

    Contact: Study coordinator (Xiaofan Liu) · liuxiaofan@ihcams.ac.cn · +86 13752006059
    Contact: Principal Investigator (Lei Zhang)
Study leads

  • Lei Zhang, M.D., Ph.D

    Principal Investigator

    Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)